People In Brief
This article was originally published in The Tan Sheet
Executive Summary
Winckler heads FDLI: The Food and Drug Law Institute names Susan Winckler, a former FDA chief of staff, as its president and CEO. Effective Nov. 6, Winckler replaced James Kelly, who announced his departure at the end of the summer. Winckler, a pharmacist and attorney who also has been VP of policy and communications and staff counsel for the American Pharmacists Association, joined FDA as director for policy communications in September 2006 under former Commissioner Andrew von Eschenbach, coordinating staff activities in the Office of the Commissioner and serving as the principal liaison to the Department of Health and Human Services. In January 2007 she took on a stronger formal role in FDA's newly created Office of the Chief of Staff, where she served as the main point of contact between the agency's centers and offices and the commissioner. Winckler left FDA in June after Commissioner Margaret Hamburg began appointing her own executive staff (1"The Tan Sheet" July 27, 2009)
You may also be interested in...
Commissioner Hamburg: Moving FDA Beyond A Regulatory Agency
Of the leading candidates for FDA commissioner in the Obama administration, Margaret Hamburg seemed among those with the least relevant experience -- an illustrious career to be sure, but one that lacked a decision-making role involving medical products
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands